Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Our innovative AI engine is revolutionizing the drug discovery process, enabling the creation of superior medications at an accelerated pace. The breakthroughs we achieve contribute to the development of medicines more efficiently and effectively. Our portfolio of AI-driven discoveries encompasses entirely owned and collaboratively developed pipeline assets, supported by leading investors in the industry. Atomwise has engineered a cutting-edge machine-learning discovery platform that merges the capabilities of convolutional neural networks with extensive chemical libraries to identify new small-molecule treatments. The key to transforming drug discovery through AI lies in our talented team. We are committed to enhancing our AI platform and leveraging it to revolutionize the discovery of small molecule drugs. It is essential that we confront the most daunting and seemingly insurmountable targets, streamlining the entire drug discovery process to provide developers with increased opportunities for success. Enhanced computational efficiency allows us to screen trillions of compounds virtually, significantly boosting the chances of finding viable solutions. Our impressive model accuracy has successfully addressed the persistent issue of false positives, underscoring the reliability of our approach. Ultimately, our dedication to innovation and excellence sets us apart in the quest for breakthrough therapies.
Description
Our innovative affective AI platform, DeepAffex, identifies, quantifies, and interprets human emotions manifested through both physiological and psychological states. This cloud-based solution employs sophisticated machine learning models to analyze these human affects, ensuring that all computational tasks are handled seamlessly in the cloud environment. Developers have the opportunity to create their own applications or software solutions utilizing our SDK/API, enabling them to retrieve measurement results from the DeepAffex cloud service across a variety of devices, including smartphones, tablets, desktops, kiosks, and web browsers. Additionally, accessing updates from our cloud service is straightforward, allowing users to enhance their capabilities with new measurement features effortlessly. The DeepAffex dashboard serves as a web-based management interface, designed specifically for developers and system administrators, providing a secure way for authorized personnel to oversee their organization’s private accounts on the DeepAffex cloud. With its user-friendly design, DeepAffex aims to streamline the integration of affective analysis into various applications, fostering enhanced emotional intelligence in technology.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Atomwise
Founded
2012
Country
United States
Website
www.atomwise.com
Vendor Details
Company Name
NuraLogix
Country
Canada
Website
nuralogix.ai/deep-affex/